Results 121 to 130 of about 57,560 (274)

Association of Penicillin Allergy Label With Post‐COVID‐19 Condition and Subsequent Clinical Outcomes: A Population‐Based Cohort Study

Clinical &Experimental Allergy, EarlyView.
Ubonphan Chaichana, Kenneth K. C. Man, Chengsheng Ju, Yogini H. Jani, Li Wei   +4 more
wiley   +1 more source

Appropriate Medical Therapy Primarily Modifies Type 2 and Severity Biomarkers in Chronic Rhinosinusitis

International Forum of Allergy &Rhinology, Volume 16, Issue 6, Page 595-606, June 2026.
ABSTRACT Background Appropriate medical therapy (AMT) is first‐line treatment for patients with chronic rhinosinusitis (CRS). We evaluated inflammatory structure, treatment‐induced changes, and biomarker‐outcome associations in AMT‐managed patients. Methods Fifty‐one CRS patients were evaluated before and after AMT which included a combination of oral ...
Asher C. Park, Brooke N. Gleason, Eli Stein, Saied Ghadersohi, Atsushi Kato, Stephanie Shintani‐Smith, David B. Conley, Kevin C. Welch, Robert C. Kern, Bruce K. Tan   +9 more
wiley   +1 more source

Clarithromycin adjunct treatment leads to substantial financial savings in community-acquired pneumonia: sub-analysis of the ACCESS trial

Journal of Global Antimicrobial Resistance
BACKGROUND: In the ACCESS randomized controlled trial addition of oral clarithromycin 500mg two times daily for seven days to standard-of-care (SoC) antibiotics provided substantial clinical benefit in adult patients hospitalized for community-acquired ...
Vasiliki Rapti, Elisavet Tasouli, Antigone Kotsaki, Georgios Niotis, Marios Chatzopoulos, Eirini Christaki, Evangelos J. Giamarellos Bourboulis, Garyphalia Poulakou   +7 more
doaj   +1 more source

Clarithromycin resistance and prevalence of Helicobacter pylori virulent genotypes in patients from Southern México with chronic gastritis.

Infection, Genetics and Evolution, 2016
In developing countries, clarithromycin resistance and frequency of re-infection are factors that contribute to high prevalence of Helicobacter pylori infection.
Judit Alarcón-Millán, G. Fernández-Tilapa, E. Cortés-Malagón, Carlos A Castañón-Sánchez, José De Sampedro-Reyes, I. Cruz-del Carmen, R. Betancourt-Linares, A. Román-Román   +7 more
semanticscholar   +1 more source

Severe and disseminated atypical mycobacteriosis of the skin under immunosuppression

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 6, Page 806-808, June 2026.
Veronika Zenderowski, Laura Schreieder, Mark Berneburg, Dennis Niebel, Sebastian Haferkamp, Sigrid Karrer, Konstantin Drexler   +6 more
wiley   +1 more source

Assessing transporter‐mediated rifampin–linezolid interaction using physiologically‐based pharmacokinetic modelling

British Journal of Clinical Pharmacology, Volume 92, Issue 6, Page 1845-1856, June 2026.
Abstract Aims The study aims to develop a physiologically‐based pharmacokinetic (PBPK) model to quantitatively evaluate the role of ATP‐binding cassette sub‐family B member 1 (ABCB1) and ATP‐binding cassette super‐family G member 2 (ABCG2) in the drug–drug interaction (DDI) between rifampin and linezolid and to predict the impact of high‐dose rifampin ...
Hoang Dat Nguyen, Vinh Hoa Pham, Richard M. Hoglund, Joel Tarning, Junjie Ding   +4 more
wiley   +1 more source

Clarithromycin attenuates cyclophosphamide-induced mucositis in mice

, 2000
No universally recognized agent is available for prophylaxis or therapy of mucositis induced by chemotherapy or chemo-radiotherapy. The effect of clarithromycin on the severity of mucositis induced by cyclophosphamide was investigated using a mouse model.
Woo, PCY, Ng, WF, Leung, HCH, Tsoi, HW, Yuen, KY   +4 more
core   +1 more source

Detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones in Brazil: A national survey

World Journal of Gastroenterology, 2016
AIM To evaluate bacterial resistance to clarithromycin and fluoroquinolones in Brazil using molecular methods. METHODS The primary antibiotic resistance rates of Helicobacter pylori (H.
B. Sanches, G. Martins, K. Lima, B. Cota, L. Moretzsohn, L. Ribeiro, H. Breyer, I. Maguilnik, A. B. Maia, J. Rezende-filho, Ana Carolina Meira, Henrique J. Pinto, Edson J. Alves, R. Mascarenhas, R. Passos, Julia Duarte de Souza, O. R. Trindade, L. Coelho   +17 more
semanticscholar   +1 more source

A Robust and Universal LC–MS/MS Method for Determination of N‐Nitrosodimethylamine in Pharmaceuticals Using a C30 Column

Journal of Separation Science, Volume 49, Issue 6, June 2026.
ABSTRACT Since the 2018 valsartan recall, the genotoxic impurity N‐nitrosodimethylamine (NDMA) has been frequently detected in various pharmaceuticals. Matrix variability often complicates routine testing, requiring customized analyses. We developed a universal LC–MS/MS method enabling consistent NDMA detection across diverse pharmaceuticals ...
Byungchan An, Unyong Kim, Sumin Seo, Jiyu Kim, Chohee Jeong, Woojin Jeong, Eunjin Ko, Juhyeon Kim, Hyun‐Deok Cho, Sang Beom Han   +9 more
wiley   +1 more source

Clarithromycin sustained-release tablet may be an improper therapy for the eradication of

Therapeutic Advances in Gastroenterology
Background: Clarithromycin plays an important role in eradicating Helicobacter pylori ( H. pylori ) through quadruple therapy. However, there is limited research on whether different forms of clarithromycin dosage have similar efficacies against H ...
Xingsheng Zuo, Qingli Shen, Jing Luo, Yaqin Wang, Chenglong Zhao   +4 more
doaj   +1 more source